Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 1
1977 3
1978 2
1979 3
1980 2
1981 1
1982 1
1984 2
1985 1
1986 3
1987 2
1988 1
1989 5
1990 3
1991 1
1992 2
1993 2
1994 2
1995 2
1996 1
1999 1
2000 1
2003 1
2004 1
2006 2
2007 2
2008 2
2009 1
2010 1
2011 1
2012 6
2013 4
2014 6
2015 4
2016 4
2017 9
2018 5
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 25341723

90 results
Results by year
Filters applied: . Clear all
Page 1
Circulating complement levels and C3 glomerulopathy.
Fervenza FC, Sethi S. Fervenza FC, et al. Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1829-31. doi: 10.2215/CJN.09620914. Epub 2014 Oct 23. Clin J Am Soc Nephrol. 2014. PMID: 25341723 Free PMC article. No abstract available.
Defining the complement biomarker profile of C3 glomerulopathy.
Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ. Zhang Y, et al. Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1876-82. doi: 10.2215/CJN.01820214. Epub 2014 Oct 23. Clin J Am Soc Nephrol. 2014. PMID: 25341722 Free PMC article.
A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy CW, Forristal J, Strife CF, West CD. Clardy CW, et al. Clin Immunol Immunopathol. 1989 Mar;50(3):333-47. doi: 10.1016/0090-1229(89)90141-4. Clin Immunol Immunopathol. 1989. PMID: 2917424
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G; Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi. Iatropoulos P, et al. J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13. J Am Soc Nephrol. 2018. PMID: 29030465 Free PMC article.
Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.
Hulton SA, Risdon RA, Dillon MJ. Hulton SA, et al. Pediatr Nephrol. 1992 May;6(3):239-43. doi: 10.1007/BF00878356. Pediatr Nephrol. 1992. PMID: 1616831
Anti-Factor B Antibodies and Acute Postinfectious GN in Children.
Chauvet S, Berthaud R, Devriese M, Mignotet M, Vieira Martins P, Robe-Rybkine T, Miteva MA, Gyulkhandanyan A, Ryckewaert A, Louillet F, Merieau E, Mestrallet G, Rousset-Rouvière C, Thervet E, Hogan J, Ulinski T, Villoutreix BO, Roumenina L, Boyer O, Frémeaux-Bacchi V. Chauvet S, et al. J Am Soc Nephrol. 2020 Apr;31(4):829-840. doi: 10.1681/ASN.2019080851. Epub 2020 Feb 7. J Am Soc Nephrol. 2020. PMID: 32034108
Hypocomplementemia in a newborn infant caused by placental transfer of C3 nephritic factor.
Kim Y, Shvil Y, Michael AF. Kim Y, et al. J Pediatr. 1978 Jan;92(1):88-90. doi: 10.1016/s0022-3476(78)80083-3. J Pediatr. 1978. PMID: 619090 No abstract available.
Does nephritic factor relate to the disease activity in hypocomplementemic membranoproliferative glomerulonephritis?
Ohi H, Tanuma Y. Ohi H, et al. Nephron. 1992;62(1):116. doi: 10.1159/000187012. Nephron. 1992. PMID: 1436279 Free article. No abstract available.
High prevalence of hepatitis C virus antibodies in older patients with membranoproliferative glomerulonephritis.
Ohsawa I, Ohi H, Endo M, Fujita T, Seki M, Watanabe S. Ohsawa I, et al. Nephron. 1999;82(4):366-7. doi: 10.1159/000045459. Nephron. 1999. PMID: 10450046 No abstract available.
Complement activation in acute glomerulonephritis in children.
Levy M, Sich M, Pirotzky E, Habib R. Levy M, et al. Ric Clin Lab. 1980 Jan-Mar;10(1):87-91. doi: 10.1007/BF02984910. Ric Clin Lab. 1980. PMID: 7008160 No abstract available.
90 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback